SCHEMBL54728

SCHEMBL54728

c1ccc2cc3cc4cc5cc6cc7ccccc7cc6cc5cc4cc3cc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
HSD17B10 Q99714 4/20 0.61
TDP1 Q9NUW8 3/20 0.61
CYP3A4 P08684 2/20 0.61
CASP1 P29466 2/20 0.61
CASP7 P55210 2/20 0.61
HIF1A Q16665 2/20 0.61
ALOX15 P16050 1/20 0.61
HBB P68871 1/20 0.61
CYP2A6 P11509 7/20 0.58
ALOX12 P18054 1/20 0.58
HPGD P15428 2/20 0.53
MAPT P10636 2/20 0.53
GLA P06280 1/20 0.53
ACHE P22303 1/20 0.53
NQO2 P16083 1/20 0.50
CYP1A2 P05177 3/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25125 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL25181 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL3474922 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL3798534 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL7947 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL719854 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL17849077 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
Benz(B)Anthracene SCHEMBL22352910 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL22634171 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1
SCHEMBL31213566 1.00 ALDH1A1 (0.61) ALDH1A1HSD17B10TDP1CYP3A4CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354054-A1 PROPPANTS DERIVED FROM CROSSLINKING MIXED AROMATIC RESINS EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2025-11-20 US claimed
US-12303876-B2 Methods for cellulose hydrolysis using sulfonated polyaromatic catalysts BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2025-05-20 US claimed
WO-2024238435-A1 N,S-DOPED ACENES, METHOD OF SYNTHESIS, ELECTROCHEMICAL SCREENING, AND USE OF SAME FOR BATTERY FABRICATION RESEARCH TRIANGLE INSTITUTE (US) 2024-11-21 WO claimed
WO-2024029292-A1 COMPOSITION, COMPOUND, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE JSR株式会社 2024-02-08 WO claimed
US-20230279286-A1 PROPPANTS DERIVED FROM CROSSLINKING MIXED AROMATIC RESINS ExxonMobil Technology and Engineering Company (US) 2023-09-07 US claimed
WO-2023168192-A1 PROPPANTS DERIVED FROM CROSSLINKING MIXED AROMATIC RESINS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2023-09-07 WO claimed
EP-3994207-B1 HNBR VULCANISATES CONTAINING POLYCYCLIC AROMATIC HYDROCARBONS ARLANXEO DEUTSCHLAND GMBH (DE) 2023-08-09 EP claimed
US-20230170467-A1 BATTERY ANODE MATERIAL AND METHOD FOR MANUFACTURING THE SAME KOREA PHOTONICS TECHNOLOGY INSTITUTE (KR) 2023-06-01 US claimed
US-20230170423-A1 MEMORY DEVICE CAPABLE OF MULTI-LEVEL DRIVING THE INDUSTRY & ACADEMIC COORPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) 2023-06-01 US claimed
CN-116190582-A Battery negative electrode material for improving battery performance and service life and preparation method thereof 韩国光技术院 2023-05-30 CN claimed
US-20070255076-A1 Method for Deuteration of an Aromatic Ring WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2007-11-01 US claimed
CN-1296331-C Method for deuteration of aromatic ring WAKO PURE CHEM IND LTD (JP) 2007-01-24 CN claimed
CN-1675145-A Method of deuterating aromatic ring WAKO PURE CHEM IND LTD (JP) 2005-09-28 CN claimed
EP-1535889-A1 METHOD OF DEUTERATING AROMATIC RING Wako Pure Chemical Industries, Ltd. (JP) 2005-06-01 EP claimed
US-6054211-A CONTAINING A PERFLUOROPOLYETHER COMPOUND, ONE OR MORE OF PORPHYRIN, PHTHALOCYANINE AND DERIVATIVES THEREOF AND A SUBSTANCE REACTING WITH WITH HYDROFLUORIC ACID AT A HIGHER RATE THAN A THAT WITH THE PERFLUOROPOLYETHER NEC CORPORATION (JP) 2000-04-25 US claimed
US-5055212-A Oil compositions containing alkyl mercaptan derivatives of copolymers of an alpha olefin or an alkyl vinyl ether and an unsaturated alpha, beta-dicarboxylic compound CONOCO INC. (US) 1991-10-08 US claimed
US-4992080-A Crude oil mixture having a depressed pour point CONOCO INC. (US) 1991-02-12 US claimed
US-4900331-A ADDITIVES FOR POUR POINT, VISCOSITY CONOCO INC. (US) 1990-02-13 US claimed
EP-0155177-A2 Unsaturated cyclic amido-substituted ether compounds and preparation process thereof MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-09-18 EP claimed
US-4247334-A CONDENSATION OF AROMATIC SULFONIC ACID WITH FORMALDEHYDE, LITHIUM HYDROXIDE RHONE-POULENC INDUSTRIES (FR) 1981-01-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255076-A1 Method for Deuteration of an Aromatic Ring HRH3, HRH4, AHR ALDH1A1 2654/4885HSD17B10 349/4885TDP1 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.